ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)
CUSIP: 45256X103
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,124,549,707
- Total 13F shares
- 79,547,067
- Share change
- -2,979,135
- Total reported value
- $239,251,849
- Put/Call ratio
- 252%
- Price per share
- $3.01
- Number of holders
- 205
- Value change
- -$5,452,987
- Number of buys
- 116
- Number of sells
- 70
Quarterly Holders Quick Answers
What is CUSIP 45256X103?
CUSIP 45256X103 identifies IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45256X103:
Top shareholders of IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
17,328,229
|
$44,360,266 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
1.2%
|
13,584,742
|
$34,776,940 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.87%
|
9,785,157
|
$25,050,002 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.36%
|
4,005,814
|
$10,254,884 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
3,840,918
|
$9,834,972 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.31%
|
3,442,440
|
$8,812,646 | — | 31 Dec 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.27%
|
3,000,000
|
$7,680,000 | — | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.25%
|
2,814,192
|
$7,204,332 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.14%
|
1,587,689
|
$4,064,484 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
1,323,424
|
$3,387,966 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
1,276,673
|
$3,268,283 | — | 31 Dec 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.11%
|
1,221,734
|
$3,127,639 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
1,141,536
|
$2,922,332 | — | 31 Dec 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.09%
|
1,060,000
|
$2,713,600 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.09%
|
1,041,863
|
$2,667,169 | — | 31 Dec 2024 | |
| Clearwater Capital Advisors, LLC |
13F
|
Company |
0.08%
|
846,419
|
$2,166,833 | — | 31 Dec 2024 | |
| ALLEN HOLDING INC /NY |
13F
|
Company |
0.06%
|
687,571
|
$1,760,182 | — | 31 Dec 2024 | |
| SHEETS SMITH WEALTH MANAGEMENT |
13F
|
Company |
0.06%
|
633,975
|
$1,622,976 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
563,911
|
$1,443,612 | — | 31 Dec 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.05%
|
549,905
|
$1,407,757 | — | 31 Dec 2024 | |
| Accurate Wealth Management, LLC |
13F
|
Company |
0.05%
|
560,000
|
$1,355,200 | — | 31 Dec 2024 | |
| Ghisallo Capital Management LLC |
13F
|
Company |
0.04%
|
500,000
|
$1,280,000 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
499,528
|
$1,278,791 | — | 31 Dec 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.04%
|
498,429
|
$1,275,978 | — | 31 Dec 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.04%
|
490,300
|
$1,255,168 | — | 31 Dec 2024 | |
| John C. Thomas |
3/4/5
|
Former Director |
—
class O/S missing
|
216,363
|
$1,086,143 | — | 31 Dec 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
396,484
|
$1,015,001 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.03%
|
384,576
|
$984,514 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.03%
|
355,302
|
$909,574 | — | 31 Dec 2024 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.03%
|
295,950
|
$793,146 | — | 31 Dec 2024 | |
| Swiss National Bank |
13F
|
Company |
0.02%
|
274,000
|
$701,440 | — | 31 Dec 2024 | |
| Sculptor Capital LP |
13F
|
Company |
0.02%
|
270,800
|
$693,248 | — | 31 Dec 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.02%
|
261,734
|
$670,041 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
260,733
|
$667,476 | — | 31 Dec 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.02%
|
257,449
|
$659,069 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
252,075
|
$645,312 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.02%
|
240,311
|
$615,197 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
234,078
|
$599,240 | — | 31 Dec 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.02%
|
233,500
|
$597,760 | — | 31 Dec 2024 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.02%
|
222,380
|
$569,293 | — | 31 Dec 2024 | |
| Clearstead Advisors, LLC |
13F
|
Company |
0.02%
|
216,200
|
$553,472 | — | 31 Dec 2024 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.02%
|
196,200
|
$548,000 | — | 31 Dec 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
214,030
|
$547,917 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
207,787
|
$531,922 | — | 31 Dec 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.01%
|
167,200
|
$428,032 | — | 31 Dec 2024 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.01%
|
153,000
|
$425,340 | — | 31 Dec 2024 | |
| China Universal Asset Management Co., Ltd. |
13F
|
Company |
0.01%
|
147,754
|
$378,250 | — | 31 Dec 2024 | |
| MIRAE ASSET SECURITIES (USA) INC. |
13F
|
Company |
0.01%
|
140,880
|
$360,653 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
138,605
|
$354,828 | — | 31 Dec 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.01%
|
131,364
|
$336,291 | — | 31 Dec 2024 |
Institutional Holders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) as of Q1 2025
As of 31 Mar 2025,
ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) was held by
205 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
79,547,067 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Woodline Partners LP, CITIGROUP INC, TANG CAPITAL MANAGEMENT LLC, MORGAN STANLEY, UBS Group AG, and NORTHERN TRUST CORP.
This page lists
206
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
193
Q1 2025 holders
205
Holder diff
12
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.